Archer Insights wins Gold Stevie Award for digital infrastructure behind life saving innovations

Archer Insights received the Gold Stevie Award in the Achievement in Science or Technology category at the 2026 American Business Awards. The winning entry, Building the Digital Infrastructure Behind Life Saving Innovations, recognizes the firm’s specialized NetSuite work for life sciences and healthcare organizations.

Archer Insights wins Gold Stevie Award for digital infrastructure behind life saving innovations

Published on archerinsights.com | News category: Awards | Vertical tags: Biotech, Biopharma, CDMO

What was announced

Archer Insights, LLC has been named a Gold Stevie Award winner in the Achievement in Science or Technology category at the 2026 American Business Awards. The recognition was issued for the firm's work building the digital infrastructure that supports life sciences and healthcare organizations developing life saving therapies. Headquartered in Philadelphia, Pennsylvania, Archer Insights was selected from a national field of nominees evaluated by independent judges of the American Business Awards program.

Why it matters

Life sciences companies, from clinical stage biotech to commercial biopharma and CDMOs, operate under regulatory requirements that generic ERP deployments cannot meet without significant configuration. 21 CFR Part 11 governs electronic records and signatures. ASC 606 dictates how clinical milestone and royalty revenue is recognized. DSCSA requires traceability that touches every transaction in the specialty pharmacy supply chain. The financial systems that sit underneath drug development decide how quickly a team can close the books, defend an audit, or shift resources to a promising trial.

The Gold Stevie recognition reflects Archer's focus on this layer of the industry. The firm builds NetSuite configurations and proprietary modules that match how regulated science actually operates, rather than asking life sciences teams to adapt to horizontal financial software.

What it means for clients

For finance and operations leaders at biotech, biopharma, and CDMO organizations, the recognition is one more data point in a multi year pattern. Archer Insights has now been named a NetSuite Alliance Partner Spotlight Award winner for 5 consecutive years, has been included on the Inc. 5000 list of fastest growing private companies in the United States, and has completed more than 50 life sciences and healthcare implementations. The Gold Stevie Award adds independent recognition from outside the NetSuite ecosystem, evaluated specifically on scientific and technological achievement.

Existing clients should expect no change in service. Prospective clients evaluating NetSuite partners can use this recognition as one external signal of capability among others, alongside named case studies in specialty pharmacy, compounding, and clinical stage biotech.

The work that earned this award is the same work we do every week. Configuring revenue recognition for a Series C biotech ahead of a Phase III readout. Building lot traceability for a 503B outsourcing facility. The recognition matters because it documents what we already do.

About Archer Insights

Archer Insights, LLC is a NetSuite Alliance Partner serving life sciences and healthcare organizations. The firm operates 4 service lines: new NetSuite implementations, enhancement services, proprietary software modules, and managed services. Archer Insights has been recognized as a NetSuite Alliance Partner Spotlight Award winner for 5 consecutive years from 2022 through 2026 and has been named to the Inc. 5000 list of fastest growing private companies in the United States. The firm is headquartered in Philadelphia, Pennsylvania, and serves clients across biotech, biopharma, CDMOs, specialty pharmacy, compounding pharmacy, medical device, and multi site healthcare operators.